# EDGAR Filing Document

**Accession Number:** 0000939930
**File Stem:** 0001567619-23-003622
**Filing Date:** 2023-2
**Character Count:** 12535
**Document Hash:** cad4e0d2eda56dc41b724a9d09cb9642
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001567619-23-003622.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001567619-23-003622

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230221

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Monarch Alternative Capital LP
- **CENTRAL INDEX KEY:** 0001281084
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25734
- **FILM NUMBER:** 23660143

**BUSINESS ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-554-1700

**MAIL ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Quadrangle Debt Recovery Advisors LP
- **DATE OF NAME CHANGE:** 20070125

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Quadrangle Debt Recovery Advisors LLC
- **DATE OF NAME CHANGE:** 20061013

**FORMER NAME:**
- **FORMER CONFORMED NAME:** QDRA LLC
- **DATE OF NAME CHANGE:** 20040223
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** MDRA GP LP
- **CENTRAL INDEX KEY:** 0001501101
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25734
- **FILM NUMBER:** 23660142

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MONARCH ALTERNATIVE CAPITAL LP
- **STREET 2:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-554-1700

**MAIL ADDRESS:**
- **STREET 1:** C/O MONARCH ALTERNATIVE CAPITAL LP
- **STREET 2:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Monarch GP LLC
- **CENTRAL INDEX KEY:** 0001501100
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25734
- **FILM NUMBER:** 23660141

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MONARCH ALTERNATIVE CAPITAL LP
- **STREET 2:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-554-1700

**MAIL ADDRESS:**
- **STREET 1:** C/O MONARCH ALTERNATIVE CAPITAL LP
- **STREET 2:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PYXUS INTERNATIONAL, INC.
- **CENTRAL INDEX KEY:** 0000939930
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-FARM PRODUCT RAW MATERIALS [5150]
- **IRS NUMBER:** 541746567
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 8001 AERIAL CENTER PARKWAY
- **CITY:** MORRISVILLE
- **STATE:** NC
- **ZIP:** 27560-8413
- **BUSINESS PHONE:** 9193794300

**MAIL ADDRESS:**
- **STREET 1:** 8001 AERIAL CENTER PARKWAY
- **CITY:** MORRISVILLE
- **STATE:** NC
- **ZIP:** 27560-8413

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ALLIANCE ONE INTERNATIONAL, INC.
- **DATE OF NAME CHANGE:** 20050516

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DIMON INC
- **DATE OF NAME CHANGE:** 19950301

## Exhibit 99.1

Designated Filer: Monarch Alternative Capital LP <br> Issuer & Ticker Symbol: Pyxus International, Inc. (PYX) <br> Date of Event Requiring Statement: February 21, 2023

<u>Explanation of Responses</u>:

<sup>(1)</sup> This Form 4 is being filed on behalf of Monarch Alternative Capital LP, a Delaware limited partnership ("<u>MAC</u>"), MDRA GP LP, a Delaware limited partnership ("<u>MDRA GP</u>"), and Monarch GP LLC, a Delaware limited liability company ("<u>Monarch GP</u>" and, together with MAC and MDRA GP, the "<u>Reporting Persons</u>"). MAC serves as the investment advisor to the Monarch Funds (as defined below) with respect to the shares of Common Stock of Pyxus International, Inc. (the "<u>Issuer</u>") beneficially owned by it by virtue of the authority granted to it by the Monarch Funds to vote and dispose of the securities directly held by such Monarch Funds. MDRA GP is the general partner of MAC and Monarch GP is the general partner of MDRA GP. Each of MAC, MDRA GP and Monarch GP may be deemed to indirectly beneficially own shares of Common Stock held directly by the Monarch Funds and disclaims beneficial ownership of all such shares except to the extent of any indirect pecuniary interest therein.<br>

<br> (2) Common Stock held directly by Monarch V Select Opportunities Master Fund LP ("<u>MVSO</u>").

<br> (3) Common Stock held directly by Monarch Debt Recovery Master Fund Ltd ("<u>MDRF</u>").

<br> (4) Common Stock held directly by Monarch Capital Master Partners V LP ("<u>MCP5</u>").

<br> (5) Common Stock held directly by Monarch Capital Master Partners IV LP ("<u>MCP4</u>"),

<br> (6) Common Stock held directly by Monarch Special Opportunities Master Fund Ltd ("<u>MSOP2</u>", together with MDRF, MVSO, MCP5 and MCP4, the "<u>Monarch Funds</u>").

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Monarch Alternative Capital LP<br><sub>(Last) (First) (Middle)</sub><br>535 MADISON AVENUE<br>26TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-21 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PYXUS INTERNATIONAL, INC. [ PYX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>MDRA GP LP<br><sub>(Last) (First) (Middle)</sub><br>C/O MONARCH ALTERNATIVE CAPITAL LP<br>535 MADISON AVENUE, 26TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-21 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PYXUS INTERNATIONAL, INC. [ PYX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Monarch GP LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O MONARCH ALTERNATIVE CAPITAL LP<br>535 MADISON AVENUE, 26TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-21 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PYXUS INTERNATIONAL, INC. [ PYX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, no par value ("Common Stock") | 2023-02-21 |  | S |  | 15199 | D | $1.34 | 0 | I | See footnotes<sup>(1)(2)</sup> |
| Common Stock |  |  |  |  |  |  |  | 2985982 | I | See footnotes<sup>(1)(3)</sup> |
| Common Stock |  |  |  |  |  |  |  | 265261 | I | See footnotes<sup>(1)(4)</sup> |
| Common Stock |  |  |  |  |  |  |  | 1897178 | I | See footnotes<sup>(1)(5)</sup> |
| Common Stock |  |  |  |  |  |  |  | 976650 | I | See footnotes<sup>(1)(6)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) See Exhibit 99.1

(2) See Exhibit 99.1

(3) See Exhibit 99.1

(4) See Exhibit 99.1

(5) See Exhibit 99.1

(6) See Exhibit 99.1

**Remarks:**
Sale resulting from client-specific mandate. Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), appointed Patrick Bartels to the board of directors of the Issuer as its designee pursuant to Section 2.1(d) of the Shareholders Agreement. As a result, each of MAC, and by virtue of their control of MAC, MDRA GP LP and Monarch GP LLC, may be deemed to be a  "director-by-deputization" of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Exhibit List:
Exhibit 99.1 - Explanation of Responses

**Signature:** MONARCH ALTERNATIVE CAPITAL LP; By: MDRA GP LP, its General Partner; By: Monarch GP LLC, its General Partner; By: /s/ Christopher Santana, Member  
**Date:** 2023-02-23

**Signature:** MDRA GP LP; By: Monarch GP LLC, its General Partner; By: /s/ Christopher Santana, Member  
**Date:** 2023-02-23

**Signature:** MONARCH GP LLC; By: /s/ Christopher Santana, Member  
**Date:** 2023-02-23

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**